At early drug discovery, purified protein-based assays are often used to characterise compound potency. In the context of dose response, it is often perceived that a time-independent inhibitor is reversible and a time-dependent inhibitor is irreversible. The legitimacy of this argument is investigated using a simple kinetics model, where it is revealed by model-based analytical analysis and numerical studies that dose response of an irreversible inhibitor may appear time-independent under certain parametric conditions. Hence, the observation of time-independence cannot be used as sole evidence for identification of inhibitor reversibility. It has also been discussed how the synthesis and degradation of a target receptor affect drug inhibiti...
An important question in drug discovery is how to overcome the significant challenge of high drug at...
A simple model simulating the kinetics of drug metabolism inhibition interaction is investigated. Th...
Binding kinetics is closely related to the efficacy of drugs. Several aspects of binding kinetics, s...
At early drug discovery, purified protein-based assays are often used to characterise compound poten...
At early drug discovery, purified protein-based assays are often used to characterise compound poten...
The potential of enzyme inhibition of a drug is frequently quantified in terms of IC50 values. While...
Reproducibility of biological data is a significant problem in research today. One potential contrib...
The Michaelis–Menten model of enzyme kinetic assumes the free ligand approximation, the steady-state...
The pharmacodynamics of drug-candidates is often optimized by metrics that describe target binding (...
The hyperbolic parabola is commonly used to summarize kinetics for enzyme reactions and receptor bin...
INTRODUCTION\nDrug-target binding kinetics are major determinants of the time course of drug actio...
Abstract: Targeting receptor systems by competitive inhibition is the objective of various antibody ...
A difficulty associated with high throughput screening for enzyme inhibitors is to establish reactio...
A difficulty associated with high throughput screening for enzyme inhibitors is to establish reactio...
Drug-target binding kinetics determine the time course of the central event in pharmac...
An important question in drug discovery is how to overcome the significant challenge of high drug at...
A simple model simulating the kinetics of drug metabolism inhibition interaction is investigated. Th...
Binding kinetics is closely related to the efficacy of drugs. Several aspects of binding kinetics, s...
At early drug discovery, purified protein-based assays are often used to characterise compound poten...
At early drug discovery, purified protein-based assays are often used to characterise compound poten...
The potential of enzyme inhibition of a drug is frequently quantified in terms of IC50 values. While...
Reproducibility of biological data is a significant problem in research today. One potential contrib...
The Michaelis–Menten model of enzyme kinetic assumes the free ligand approximation, the steady-state...
The pharmacodynamics of drug-candidates is often optimized by metrics that describe target binding (...
The hyperbolic parabola is commonly used to summarize kinetics for enzyme reactions and receptor bin...
INTRODUCTION\nDrug-target binding kinetics are major determinants of the time course of drug actio...
Abstract: Targeting receptor systems by competitive inhibition is the objective of various antibody ...
A difficulty associated with high throughput screening for enzyme inhibitors is to establish reactio...
A difficulty associated with high throughput screening for enzyme inhibitors is to establish reactio...
Drug-target binding kinetics determine the time course of the central event in pharmac...
An important question in drug discovery is how to overcome the significant challenge of high drug at...
A simple model simulating the kinetics of drug metabolism inhibition interaction is investigated. Th...
Binding kinetics is closely related to the efficacy of drugs. Several aspects of binding kinetics, s...